Enzyme kinetics and distinct modulation of the protein kinase N family of kinases by lipid activators and small molecule inhibitors
Open Access
- 18 March 2014
- journal article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 34 (2) , 93-106
Abstract
The PKN (protein kinase N) family of Ser/Thr protein kinases regulates a diverse set of cellular functions, such as cell migration and cytoskeletal organization. Inhibition of tumour PKN activity has been explored as an oncology therapeutic approach, with a PKN3-targeted RNAi (RNA interference)-derived therapeutic agent in Phase I clinical trials. To better understand this important family of kinases, we performed detailed enzymatic characterization, determining the kinetic mechanism and lipid sensitivity of each PKN isoform using full-length enzymes and synthetic peptide substrate. Steady-state kinetic analysis revealed that PKN1–3 follows a sequential ordered Bi–Bi kinetic mechanism, where peptide substrate binding is preceded by ATP binding. This kinetic mechanism was confirmed by additional kinetic studies for product inhibition and affinity of small molecule inhibitors. The known lipid effector, arachidonic acid, increased the catalytic efficiency of each isoform, mainly through an increase in kcat for PKN1 and PKN2, and a decrease in peptide KM for PKN3. In addition, a number of PKN inhibitors with various degrees of isoform selectivity, including potent (Ki<10 nM) and selective PKN3 inhibitors, were identified by testing commercial libraries of small molecule kinase inhibitors. This study provides a kinetic framework and useful chemical probes for understanding PKN biology and the discovery of isoform-selective PKN-targeted inhibitors.Keywords
This publication has 62 references indexed in Scilit:
- Functional Viability Profiles of Breast CancerCancer Discovery, 2011
- Identification of an Interaction between the TPα and TPβ Isoforms of the Human Thromboxane A2 Receptor with Protein Kinase C-related Kinase (PRK) 1Journal of Biological Chemistry, 2011
- The Rho Target PRK2 Regulates Apical Junction Formation in Human Bronchial Epithelial CellsMolecular and Cellular Biology, 2011
- Regulation of the Interaction between Protein Kinase C-related Protein Kinase 2 (PRK2) and Its Upstream Kinase, 3-Phosphoinositide-dependent Protein Kinase 1 (PDK1)Journal of Biological Chemistry, 2009
- Activation of tyrosine kinases by mutation of the gatekeeper threonineNature Structural & Molecular Biology, 2008
- The selectivity of protein kinase inhibitors: a further updateBiochemical Journal, 2007
- Rho GTPases regulate PRK2/PKN2 to control entry into mitosis and exit from cytokinesisThe EMBO Journal, 2007
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Multiple Interactions of PRK1 with RhoAJournal of Biological Chemistry, 1998
- Basic local alignment search toolJournal of Molecular Biology, 1990